- Market Realist•last month
Salix is one of Valeant’s (VRX) core businesses. To gain growth momentum, the Salix and dermatology portfolios are crucial for Valeant.
- American City Business Journals•2 months ago
Embattled drug giant Valeant Pharmaceuticals International (VRX) heard some much-needed good news when the U.S. Food and Drug Administration approved a drug that has deep roots in Raleigh. Specifically, FDA approved Relistor tablets for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. The drug was a legacy product of Salix Pharmaceuticals, the Raleigh pharmaceutical company Valeant acquired in 2015.
NasdaqGS . Currency in USD
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52wk Range||undefined - undefined|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|